Icon

MOUNJARO (AUTOINJECTOR) (nda215866)- (2.5MG/0.5ML (2.5MG/0.5ML),2.5MG/0.5ML (2.5MG/0.5ML),5MG/0.5ML (5MG/0.5ML),5MG/0.5ML (5MG/0.5ML),7.5MG/0.5ML (7.5MG/0.5ML),7.5MG/0.5ML (7.5MG/0.5ML),10MG/0.5ML (10MG/0.5ML),10MG/0.5ML (10MG/0.5ML),12.5MG/0.5ML (12.5MG/0.5ML),12.5MG/0.5ML (12.5MG/0.5ML),15MG/0.5ML (15MG/0.5ML),15MG/0.5ML (15MG/0.5ML))

TIRZEPATIDE ELI LILLY AND CO
2.5MG/0.5ML (2.5MG/0.5ML),2.5MG/0.5ML (2.5MG/0.5ML),5MG/0.5ML (5MG/0.5ML),5MG/0.5ML (5MG/0.5ML),7.5MG/0.5ML (7.5MG/0.5ML),7.5MG/0.5ML (7.5MG/0.5ML),10MG/0.5ML (10MG/0.5ML),10MG/0.5ML (10MG/0.5ML),12.5MG/0.5ML (12.5MG/0.5ML),12.5MG/0.5ML (12.5MG/0.5ML),15MG/0.5ML (15MG/0.5ML),15MG/0.5ML (15MG/0.5ML)
No No
2039-Jun-14 2027-May-13
None None
None No
MOUNJAROâ„¢ is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
0 0 0
Total Other Developers 3
Drugs with Suitability No
2.5MG/0.5ML (2.5MG/0.5ML) ** ** - - -
5MG/0.5ML (5MG/0.5ML) ** ** - - -
7.5MG/0.5ML (7.5MG/0.5ML) ** ** - - -
10MG/0.5ML (10MG/0.5ML) ** ** - - -
12.5MG/0.5ML (12.5MG/0.5ML) ** ** - - -
15MG/0.5ML (15MG/0.5ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.